A total of 322 patients with cystic lesions were examined with contrast-enhanced computed tomography from 1998 to 2005. Of them, 104 patients have undergone transperitoneal or retroperitonial laparoscopic surgery. 21 patients of the latter were diagnosed to have cystic lesions Bosniak III and 4 patients--Bosniak IV. It is difficult to differentiate cysts Bocniak II and III even pathomorphologically. Cystic carcinoma was detected histologically in 8 Bosniak III cases. Partial nephrectomy was made in 7 cases and radical nephrectomy in 1 case. Renal cell carcinoma was detected in 3 of 4 Bosniak IV cases, oncocytoma--in 1 case. Thus, renal cancer was confirmed in 8 cases (38%) of Bosniak III and 3 cases of Bosniak IV. During the mean follow-up of 40 months no events of local recurrence, progression or tumor growth in places of trocar installation were detected. Cases of cancer specific mortality were not observed. Cystic lesion Bosniak III and IV are subject for surgical treatment. The method of choice is laparoscopic transperitoneal partial nephrectomy and radical nephrectomy.
Download full-text PDF |
Source |
---|
AJR Am J Roentgenol
January 2025
Associate Professor, University of Ottawa Department of Radiology. Clinical Epidemiology Program, Ottawa Hospital Research Institute. Room c159 Ottawa Hospital Civic Campus, 1053 Carling Ave. Ottawa, ON, K1Y 4E9.
Bosniak classification version 2019 (v2019) was a major revision to version 2005 (v2005) that defined cystic renal mass subclasses based on wall or septa features. To determine the proportion of malignancy within cystic renal masses stratified by Bosniak classification v2019 class and feature-based subclass. MEDLINE and EMBASE databases were searched on July 24, 2023 for studies published in 2019 or later that reported cystic renal masses that underwent renal-mass CT or MRI, were assessed using Bosniak v2019, and had a reference standard (histopathology indicating benignity or malignancy or ≥5-year imaging follow-up indicating benignity).
View Article and Find Full Text PDFBMC Cancer
December 2024
Department of Urology, Peking University Third Hospital, 49 Huayuan North Road, Haidian District, Beijing, 100191, P.R. China.
Rationale And Objectives: The management of complex renal cysts is guided by the Bosniak classification system, which may be inadequate for risk stratification of patients to determine the appropriate intervention. Radiomics models based on CT imaging may provide additional useful information.
Materials And Methods: A total of 322 patients with Bosniak II-IV cysts were included in the study from January 2010 to December 2019.
Int J Surg Pathol
November 2024
Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Mucinous borderline tumors of the pelvicalyceal system are exceedingly rare tumors with very little information regarding their clinicopathological characteristics and molecular underpinnings in the published literature. Herein, we report two mucinous borderline tumors and review the literature pertaining to these tumors. The patients were women who presented with flank pain without any history of nephrolithiasis.
View Article and Find Full Text PDFFP Essent
August 2024
Urology Division, Department of Surgery, Womack Army Medical Center.
Kidney cysts and tumors often are identified during imaging for unrelated issues. Kidney cysts can be attributable to heritable polycystic kidney diseases. These cysts are rare in children.
View Article and Find Full Text PDFFront Oncol
May 2024
Department of Urology, Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Beijing, China.
Objectives: This study aimed to explore the feasibility and safety of laparoscopic nephron-sparing surgery (LNSS) for complex renal cystic lesions.
Methods: A retrospective study was conducted on 83 cases of complex renal cystic lesions treated with LNSS in our hospital. There were 32 men and 51 women, ranging in age from 24 to 73 years (average, 47.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!